Anti-Influenza Virus (H5N1) Activity Screening on the Phloroglucinols from Rhizomes of Dryopteris crassirhizoma

Molecules. 2017 Mar 8;22(3):431. doi: 10.3390/molecules22030431.

Abstract

For screening the active phloroglucinols on influenza virus (H5N1) from Dryopteris crassirhizoma NaKai, a database was established including twenty-three phloroglucinols that had been isolated from Dryopteris crassirhizoma. Their inhibitory effect on the neuraminidase (NA) of influenza virus H5N1 was screened by molecular docking. As a result, three candidates were selected. The rhizomes of D. crassirhizoma were subjected to isolation and purification processes to obtain the inhibitor candidates. Thirteen phloroglucinols were obtained, including three selected candidates and two new phloroglucinols. The five phloroglucinols were investigated for their inhibitory activity on NA in vitro. The results showed that dryocrassin ABBA and filixic acid ABA exhibited inhibitory effects on NA with IC50 as 18.59 ± 4.53 and 29.57 ± 2.48 μM, respectively, and the other three phloroglucinols showed moderate inhibitory activity. Moreover, the anti-influenza virus (H5N1) activity and cytotoxicity of dryocrassin ABBA and filixic acid ABA were tested on Madin-Darby canine kidney (MDCK) cells with the cell counting kit-8 (CCK8) method. The results confirmed that dryocrassin ABBA exhibited an inhibitory activity with low cytotoxicity (TC50 > 400 μM) against influenza virus (H5N1) which will have to be investigated in further detail. In conclusion, phloroglucinols from D. crassirhizoma were shown to have anti-influenza virus activity, and especially dryocrassin ABBA, one of the phloroglucinols, may have the potential to control influenza virus (H5N1) infection.

Keywords: Dryopteris crassirhizoma; dryocrassin ABBA; influenza virus H5N1; neuraminidase; phloroglucinols.

MeSH terms

  • Animals
  • Antiviral Agents / chemistry*
  • Antiviral Agents / pharmacology*
  • Binding Sites
  • Catalytic Domain
  • Dryopteris / chemistry*
  • Enzyme Activation / drug effects
  • Humans
  • Influenza A Virus, H5N1 Subtype / drug effects*
  • Magnetic Resonance Spectroscopy
  • Microbial Sensitivity Tests
  • Models, Molecular
  • Molecular Conformation
  • Molecular Docking Simulation
  • Neuraminidase / antagonists & inhibitors
  • Neuraminidase / chemistry
  • Phloroglucinol / chemistry*
  • Phloroglucinol / pharmacology*
  • Protein Binding
  • Quantitative Structure-Activity Relationship
  • Rhizome / chemistry*
  • Spectrometry, Mass, Electrospray Ionization
  • Viral Proteins / antagonists & inhibitors
  • Viral Proteins / chemistry

Substances

  • Antiviral Agents
  • Viral Proteins
  • Phloroglucinol
  • NA protein, influenza A virus
  • Neuraminidase